<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Retinoic Acid Negatively Impacts Proliferation and MC TC Specific Attributes of Human Skin Derived Mast Cells, but Reinforces Allergic Stimulability</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2017-02-28">28 February 2017</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Magda</forename><surname>Babina</surname></persName>
							<email>magda.babina@charite.de</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Dermatology and Allergy</orgName>
								<orgName type="institution">Charité Universitätsmedizin Berlin</orgName>
								<address>
									<postCode>10117</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Metin</forename><surname>Artuc</surname></persName>
							<email>metin.artuc@charite.de</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Dermatology and Allergy</orgName>
								<orgName type="institution">Charité Universitätsmedizin Berlin</orgName>
								<address>
									<postCode>10117</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sven</forename><surname>Guhl</surname></persName>
							<email>sven.guhl@gmx.de</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Dermatology and Allergy</orgName>
								<orgName type="institution">Charité Universitätsmedizin Berlin</orgName>
								<address>
									<postCode>10117</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Torsten</forename><surname>Zuberbier</surname></persName>
							<email>torsten.zuberbier@charite.de</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Dermatology and Allergy</orgName>
								<orgName type="institution">Charité Universitätsmedizin Berlin</orgName>
								<address>
									<postCode>10117</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Retinoic Acid Negatively Impacts Proliferation and MC TC Specific Attributes of Human Skin Derived Mast Cells, but Reinforces Allergic Stimulability</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2017-02-28">28 February 2017</date>
						</imprint>
					</monogr>
					<idno type="MD5">3FC48BE03489A0BA5D4DD4877C65F434</idno>
					<idno type="DOI">10.3390/ijms18030525</idno>
					<note type="submission">Received: 16 November 2016; Accepted: 21 February 2017</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:15+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>mast cell</term>
					<term>retinoic acid</term>
					<term>skin</term>
					<term>proliferation</term>
					<term>cell cycle</term>
					<term>IgER</term>
					<term>tryptase</term>
					<term>chymase</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>The Vitamin-A-metabolite retinoic acid (RA) acts as a master regulator of cellular programs.</s><s>Mast cells (MCs) are primary effector cells of type-I-allergic reactions.</s><s>We recently uncovered that human cutaneous MCs are enriched with RA network components over other skin cells.</s><s>Yet, direct experimental evidence on the significance of the RA-MC axis is limited.</s><s>Here, skin-derived cultured MCs were exposed to RA for seven days and investigated by flow-cytometry (BrdU incorporation, Annexin/PI, FcεRI), microscopy, RT-qPCR, histamine quantitation, protease activity, and degranulation assays.</s><s>We found that while MC size and granularity remained unchanged, RA potently interfered with MC proliferation.</s><s>Conversely, a modest survival-promoting effect from RA was noted.</s><s>The granule constituents, histamine and tryptase, remained unaffected, while RA had a striking impact on MC chymase, whose expression dropped by gene and by peptidase activity.</s><s>The newly uncovered MRGPRX2 performed similarly to chymase.</s><s>Intriguingly, RA fostered allergic MC degranulation, in a way completely uncoupled from FcεRI expression, but it simultaneously restricted MRGPRX2-triggered histamine release in agreement with the reduced receptor expression.</s><s>Vitamin-A-derived hormones thus re-shape skin-derived MCs numerically, phenotypically, and functionally.</s><s>A general theme emerges, implying RA to skew MCs towards processes associated with (allergic) inflammation, while driving them away from the skin-imprinted MC TC ("MCs containing tryptase and chymase") signature (chymase, MRGPRX2).</s><s>Collectively, MCs are substantial targets of the skin retinoid network.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">Introduction</head><p><s>Mast cells (MCs), unique elements of the human body <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b1">2]</ref>, are of hematopoietic origin, but develop exclusively in target organs, such as the skin, and the intestinal or respiratory tracts, respectively <ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref>.</s><s>In humans, MCs are best understood for their role as effectors of IgE-mediated allergic reactions and in the skin, as intermediaries of pruritus symptoms by interaction of MC derived mediators with sensory nerves <ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref>.</s><s>Accordingly, MCs are numerically increased and/or functionally altered in skin conditions like atopic dermatitis, psoriasis and urticaria <ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref>.</s></p><p><s>The skin is not only particularly rich in MCs even in the absence of infection or inflammation <ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref>, but it is also a firmly established target of Vitamin A derivatives, of which the carboxylic acid form, all-trans retinoic acid (RA), represents the major hormonally active entity.</s></p><p><s>A tight association between the retinoid system and the skin is underscored by the amounts of RA and its precursors found in this organ and the abundance of proteins involved in RA metabolism and 2 of 15 function <ref type="bibr" target="#b14">[15,</ref><ref type="bibr" target="#b15">16]</ref>, and further substantiated by the broad therapeutic use of retinoids for skin disorders; in fact, retinoid based therapies are inclined towards dermatological conditions <ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref>.</s></p><p><s>So far, skin MCs have not been in the focus of cutaneous RA research.</s><s>This may reflect the fact that MC purification from skin is costly and laborious and the starting material not widely accessible to researchers.</s><s>We have overcome this hurdle, and routinely purify MCs from human skin to homogeneity <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b12">13,</ref><ref type="bibr" target="#b24">25,</ref><ref type="bibr" target="#b25">26]</ref>.</s></p><p><s>By interrogating the comprehensive FANTOM5 (Functional annotation of the mammalian genome 5) expression atlas, which encompasses skin MCs from our laboratory <ref type="bibr" target="#b26">[27]</ref>, we surprisingly found that it was MCs that expressed the highest levels of the most versatile retinoid receptor subtype (RARA, retinoic acid receptor alpha) across the entire atlas <ref type="bibr" target="#b27">[28]</ref>.</s><s>The extensive coverage of the atlas with nearly 1900 libraries from all parts of the body, including ~200 primary cells, as well as time-course series <ref type="bibr" target="#b26">[27,</ref><ref type="bibr" target="#b28">29]</ref>, implied an important, yet largely overlooked connection between RA and skin MCs.</s><s>Following up on this theory, we found further evidence through bioinformatics analyses, pinpointing skin MCs as highly enriched with genes pertinent to the retinoid network vis-à-vis other skin cell subsets <ref type="bibr" target="#b27">[28]</ref>.</s></p><p><s>These findings spurred further interest in the modulatory effect exerted by RA in MCs from the skin compartment.</s><s>Focusing on RA's role in mitogenesis, MC signature characteristics and functional competence, we now report that RA has a profound impact on skin-derived MCs, where it interferes with proliferation and selective attributes of the skin-dwelling MC TC subset, while simultaneously promoting allergic, yet suppressing pseudo-allergic (MRGPRX2-driven) MC degranulation.</s><s>Collectively, our study substantiates a close connection between skin MCs and the skin RA network and implies MCs as considerable elements in cutaneous retinoid biology under homeostatic and therapeutic conditions.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1.">RA Counters Proliferation but Has No Negative Impact on the Survival of Human Skin-Derived MCs</head><p><s>Even though classified as terminally differentiated cells, tissue MCs can re-enter the cell cycle if supported by sufficient amounts of stem cell factor (SCF), and this phenomenon also accounts to MCs derived from human skin <ref type="bibr" target="#b29">[30]</ref>.</s><s>Under optimal conditions, the cells require 1-2 weeks to complete one cycle of replication <ref type="bibr" target="#b25">[26,</ref><ref type="bibr" target="#b29">30,</ref><ref type="bibr" target="#b30">31]</ref> and express cell cycle regulators like E2F1 and PCNA (proliferating cell nuclear antigen) during this period <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b30">31]</ref>.</s></p><p><s>Here we found that RA counteracted the SCF-driven increment in MC numbers (Figure <ref type="figure" target="#fig_1">1A</ref>).</s><s>Addressing the mechanism, we detected that the proportion of Annexin + (i.e., apoptotic) cells was not increased but even slightly (yet significantly) diminished in the presence of RA (Figure <ref type="figure" target="#fig_1">1B</ref>).</s><s>This was supported by the expression profile of selected genes, where anti-apoptotic Mcl-1 slightly increased, while Bcl-xl as well as pro-apoptotic Bax remained unchanged by RA (Figure <ref type="figure" target="#fig_1">1C</ref>).</s></p><p><s>Therefore, RA did obviously not act by triggering cell death in our system.</s><s>We next tested whether RA affected cell cycle progression of skin-derived MCs, and found that this was indeed the case.</s><s>Using BrdU incorporation to track DNA synthesis, an anti-proliferative effect of RA, i.e., interference with SCF-driven cell cycle progression, was easily detected (Figure <ref type="figure" target="#fig_1">1D,E</ref>).</s><s>The anti-proliferative effect was accompanied by changes in selected transcripts associated with the cell cycle.</s><s>While RA did not influence p21 levels in our system, it diminished PCNA and E2F1 expression (Figure <ref type="figure" target="#fig_1">1F</ref>), two genes whose activity correlates with cell cycle progression of skin-derived MCs <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b30">31]</ref>.</s></p><p><s>The microscopic evaluation of toluidine blue stained MCs revealed intact granule architecture in RA treated MCs (Figure <ref type="figure" target="#fig_1">1G</ref>), and the cell size likewise remained unaffected in the presence of RA (mean diameter 13.94 ± 0.21 µm for SCF alone, 13.96 ± 0.18 µm for RA), suggesting that SCF-mediated cell growth was normal.</s></p><p><s>We conclude that the reduced increment in MC numbers in the presence of RA results from interference with SCF-evoked proliferation, but not from reduced viability of non-cycling MCs.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2.">Granule Constituents</head><p><s>MC granules are filled with an array of preformed mediators (especially histamine, heparin, and MC specific proteases) and represent the most salient feature of the lineage (see Figure <ref type="figure" target="#fig_1">1G</ref>).</s><s>Accordingly, transcripts for the granule-associated proteases tryptase and chymase are among the most abundant and specific MC signature genes <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b31">32,</ref><ref type="bibr" target="#b32">33]</ref>.</s><s>Histamine, on the other hand, mediates many of the clinical symptoms resulting from allergic MC activation and is therefore a major target of anti-allergic medication.</s></p><p><s>We assessed whether RA modulated cellular histamine accumulation and expression of L-histidine decarboxylase (HDC), the enzyme catalyzing the rate-limiting step in histamine formation.</s><s>Both HDC mRNA and histamine contents remained comparable in cells exposed to RA versus cells kept in SCF alone (Figure <ref type="figure" target="#fig_3">2A</ref>,B, left), even though there was a tendency of increased expression in the case of HDC gene expression (Figure <ref type="figure" target="#fig_3">2A</ref>, left).</s></p><p><s>Focusing on MC specific proteases, we found that tryptase mRNA was dampened by RA, whereas tryptase activity remained comparable between the groups (Figure <ref type="figure" target="#fig_3">2A</ref>,B, middle).</s><s>Conversely, chymase mRNA experienced a highly significant drop in the presence of RA down to approximately one third (34.7%) of control expression (Figure <ref type="figure" target="#fig_3">2A</ref>, middle).</s><s>This was accompanied</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2.">Granule Constituents</head><p><s>MC granules are filled with an array of preformed mediators (especially histamine, heparin, and MC specific proteases) and represent the most salient feature of the lineage (see Figure <ref type="figure" target="#fig_1">1G</ref>).</s><s>Accordingly, transcripts for the granule-associated proteases tryptase and chymase are among the most abundant and specific MC signature genes <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b31">32,</ref><ref type="bibr" target="#b32">33]</ref>.</s><s>Histamine, on the other hand, mediates many of the clinical symptoms resulting from allergic MC activation and is therefore a major target of anti-allergic medication.</s></p><p><s>We assessed whether RA modulated cellular histamine accumulation and expression of L-histidine decarboxylase (HDC), the enzyme catalyzing the rate-limiting step in histamine formation.</s><s>Both HDC mRNA and histamine contents remained comparable in cells exposed to RA versus cells kept in SCF alone (Figure <ref type="figure" target="#fig_3">2A</ref>,B, left), even though there was a tendency of increased expression in the case of HDC gene expression (Figure <ref type="figure" target="#fig_3">2A</ref>, left).</s></p><p><s>Focusing on MC specific proteases, we found that tryptase mRNA was dampened by RA, whereas tryptase activity remained comparable between the groups (Figure <ref type="figure" target="#fig_3">2A</ref>,B, middle).</s><s>Conversely, chymase mRNA experienced a highly significant drop in the presence of RA down to approximately one third (34.7%) of control expression (Figure <ref type="figure" target="#fig_3">2A</ref>, middle).</s><s>This was accompanied by reduced chymase activity, which showed the same tendency, even though the effect was less pronounced (decrease to 70.8% by mean, and to 66.7% by median of control) (Figure <ref type="figure" target="#fig_3">2B</ref>, middle).</s></p><p><s>Int. J. Mol.</s><s>Sci.</s><s>2017, <ref type="bibr" target="#b17">18</ref>, 525 4 of 15 by reduced chymase activity, which showed the same tendency, even though the effect was less pronounced (decrease to 70.8% by mean, and to 66.7% by median of control) (Figure <ref type="figure" target="#fig_3">2B</ref>, middle).</s><s>Collectively, RA does not impact the preformed mediators histamine and tryptase in our system.</s><s>Intriguingly, however, there is a particularly clear (negative) effect on MC chymase, a selective marker of the MCTC subcategory, i.e., MCs containing tryptase and chymase (the subset found in the skin over MCT cells, which only contain tryptase and predominate in the lung or gut).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3.">FcεRI Expression and Allergic MC Stimulation</head><p><s>FcεRI, the high affinity receptor for IgE (IgER), represents a classical functional unit of MCs and has been investigated thoroughly for its role in type-I allergic reactions <ref type="bibr" target="#b5">[6,</ref><ref type="bibr" target="#b7">8]</ref>.</s><s>In the present study, cell surface level of FcεRIα remained unchanged in the presence of RA, even though there was a tendency towards downregulated expression (Figure <ref type="figure" target="#fig_6">3A,B</ref>).</s><s>When studying the impact of RA on FcεRI-triggered degranulation responses, we found that histamine release was fostered by prior RA treatment.</s><s>In fact, a heightened release was detected in 12 out of 14 samples (donors), while one preparation showed the opposite trend and another one no impact from RA.</s><s>Despite the divergent preparation statistical probability was p &lt; 0.01 (Figure <ref type="figure" target="#fig_6">3C</ref>, right), which rose to p &lt; 0.0001 without the deviating sample (not illustrated).</s><s>In contrast, blank histamine release (i.e., release in the absence of a specific stimulus) showed no tendency in any direction and both down-and up-regulations were common (Figure <ref type="figure" target="#fig_6">3C</ref>, left).</s><s>Note that the spontaneous release is manifoldly lower than the release elicited by FcεRI aggregation (different scale on the y-axis) and also has a greater error rate.</s><s>In Figure Collectively, RA does not impact the preformed mediators histamine and tryptase in our system.</s><s>Intriguingly, however, there is a particularly clear (negative) effect on MC chymase, a selective marker of the MC TC subcategory, i.e., MCs containing tryptase and chymase (the subset found in the skin over MC T cells, which only contain tryptase and predominate in the lung or gut).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3.">FcεRI Expression and Allergic MC Stimulation</head><p><s>FcεRI, the high affinity receptor for IgE (IgER), represents a classical functional unit of MCs and has been investigated thoroughly for its role in type-I allergic reactions <ref type="bibr" target="#b5">[6,</ref><ref type="bibr" target="#b7">8]</ref>.</s><s>In the present study, cell surface level of FcεRIα remained unchanged in the presence of RA, even though there was a tendency towards downregulated expression (Figure <ref type="figure" target="#fig_6">3A,B</ref>).</s><s>When studying the impact of RA on FcεRI-triggered degranulation responses, we found that histamine release was fostered by prior RA treatment.</s><s>In fact, a heightened release was detected in 12 out of 14 samples (donors), while one preparation showed the opposite trend and another one no impact from RA.</s><s>Despite the divergent preparation statistical probability was p &lt; 0.01 (Figure <ref type="figure" target="#fig_6">3C</ref>, right), which rose to p &lt; 0.0001 without the deviating sample (not illustrated).</s><s>In contrast, blank histamine release (i.e., release in the absence of a specific stimulus) showed no tendency in any direction and both down-and up-regulations were common (Figure <ref type="figure" target="#fig_6">3C</ref>, left).</s><s>Note that the spontaneous release is manifoldly lower than the release elicited by FcεRI aggregation (different scale on the y-axis) and also has a greater error rate.</s><s>In Figure <ref type="figure" target="#fig_6">3C</ref> (right), the spontaneous release was already subtracted from the gross histamine release obtained for IgER stimulated cells (i.e., the net values are given in the figure, as detailed in the experimental section).</s><s>Histamine exteriorization under SCF saturation is very pronounced <ref type="bibr" target="#b25">[26,</ref><ref type="bibr" target="#b30">31]</ref>, reaching up to 77% of the total cellular histamine content in control cells of the current dataset (Figure <ref type="figure" target="#fig_6">3C</ref>).</s><s>Because of this, there does not seem to be much room for further intensification, and the fact that RA can actually do this and drive degranulation further up seemed quite remarkable.</s><s>We therefore asked whether RA's positive impact on IgER-triggered degranulation was dependent on the strength of the signal.</s><s>Varying the cross-linking agent over a range of 100-fold, we found a clearly supportive effect at the high and intermediate cross-linking strength, confirming the results shown in Figure <ref type="figure" target="#fig_6">3C</ref> by an independent set of MC preparations (Figure <ref type="figure" target="#fig_6">3D</ref>).</s><s>At the lowest signal strength, however, RA pre-treatment reduced degranulation, and this resulted in a changed dose-response curve for RA-treated versus control MCs with a steeper increase between 0.005 and 0.05 µg/mL in the former (Figure <ref type="figure" target="#fig_6">3D</ref>).</s><s>3C (right), the spontaneous release was already subtracted from the gross histamine release obtained for IgER stimulated cells (i.e., the net values are given in the figure, as detailed in the experimental section).</s><s>Histamine exteriorization under SCF saturation is very pronounced <ref type="bibr" target="#b25">[26,</ref><ref type="bibr" target="#b30">31]</ref>, reaching up to 77% of the total cellular histamine content in control cells of the current dataset (Figure <ref type="figure" target="#fig_6">3C</ref>).</s><s>Because of this, there does not seem to be much room for further intensification, and the fact that RA can actually do this and drive degranulation further up seemed quite remarkable.</s><s>We therefore asked whether RA's positive impact on IgER-triggered degranulation was dependent on the strength of the signal.</s><s>Varying the cross-linking agent over a range of 100-fold, we found a clearly supportive effect at the high and intermediate cross-linking strength, confirming the results shown in Figure <ref type="figure" target="#fig_6">3C</ref> by an independent set of MC preparations (Figure <ref type="figure" target="#fig_6">3D</ref>).</s><s>At the lowest signal strength, however, RA pre-treatment reduced degranulation, and this resulted in a changed dose-response curve for RA-treated versus control MCs with a steeper increase between 0.005 and 0.05 μg/mL in the former (Figure <ref type="figure" target="#fig_6">3D</ref>).</s><s>The IgER complex is expressed as a tetramer consisting of three subunits in the composition of αβγ2, where the α chain (protruding from the cell surface) is responsible for IgE binding, while the β The IgER complex is expressed as a tetramer consisting of three subunits in the composition of αβγ 2 , where the α chain (protruding from the cell surface) is responsible for IgE binding, while the β and γ chains (the former not absolutely required for complex formation) are involved in signal transduction <ref type="bibr" target="#b33">[34]</ref>.</s><s>By quantitative RT-PCR, α, β and γ specific transcripts remained unchanged in the presence of RA (Figure <ref type="figure" target="#fig_6">3E</ref>), largely in accordance with the protein expression data depicted in Figure <ref type="figure" target="#fig_6">3A,B</ref>.</s><s>We conclude that RA stimulates allergic MC activation via the FcεRI complex if the cross-linking efficiency is sufficiently pronounced.</s><s>This occurs without altered expression of the IgER complex, but by reinforced releasability via the IgER complex.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4.">Other MC Selective Traits</head><p><s>The availability of the comprehensive body-wide expression atlas pinpointed MCs as unique cellular elements of the body and identified additional genes with MC restricted or MC enriched expression.</s><s>Two examples among the uncovered MC "private genes" are T1/ST2 (IL1RL1) and MRGPRX2 <ref type="bibr" target="#b0">[1]</ref>, the former encoding the IL-33 receptor <ref type="bibr" target="#b34">[35]</ref>, the latter a G protein coupled receptor mediating so-called "pseudo-allergic" reactions <ref type="bibr" target="#b35">[36]</ref>.</s><s>Here, we investigated their modulation by RA.</s><s>CD43 (SPN), earlier reported to be an RA-responsive gene in MCs <ref type="bibr" target="#b27">[28,</ref><ref type="bibr" target="#b36">37]</ref>, served as positive control, and was confirmed to also be promoted by RA in the current study (Figure <ref type="figure" target="#fig_8">4A</ref>).</s><s>ST2/T1 as well as MRGPRX2 were robustly expressed by MCs (Figure <ref type="figure" target="#fig_8">4B,C</ref> showing expression against the highly expressed β actin gene) but not by other cell subsets (like dermal fibroblasts and several cell lines, not depicted), substantiating the results from FANTOM5 <ref type="bibr" target="#b0">[1]</ref>.</s><s>T1/ST2 gene expression remained unaffected in the presence of RA (Figure <ref type="figure" target="#fig_8">4B</ref>).</s><s>In contrast, MRGPRX2 expression substantially diminished after RA treatment down to 34.8% (Figure <ref type="figure" target="#fig_8">4C</ref>), thereby duplicating the effect on MC chymase.</s><s>MRGPRX2 is the long-sought receptor for compound 48/80, a typical MC secretagogue able to degranulate MCs of skin origin <ref type="bibr" target="#b35">[36]</ref>.</s><s>We therefore asked whether its decreased expression in RA-treated cells would be mirrored at the functional level.</s><s>This was clearly found to be the case, and compound 48/80-triggered degranulation was reduced by RA pretreatment in each MC preparation tested (Figure <ref type="figure" target="#fig_8">4D</ref>).</s><s>and γ chains (the former not absolutely required for complex formation) are involved in signal transduction <ref type="bibr" target="#b33">[34]</ref>.</s><s>By quantitative RT-PCR, α, β and γ specific transcripts remained unchanged in the presence of RA (Figure <ref type="figure" target="#fig_6">3E</ref>), largely in accordance with the protein expression data depicted in Figure <ref type="figure" target="#fig_6">3A,B</ref>.</s><s>We conclude that RA stimulates allergic MC activation via the FcεRI complex if the cross-linking efficiency is sufficiently pronounced.</s><s>This occurs without altered expression of the IgER complex, but by reinforced releasability via the IgER complex.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4.">Other MC Selective Traits</head><p><s>The availability of the comprehensive body-wide expression atlas pinpointed MCs as unique cellular elements of the body and identified additional genes with MC restricted or MC enriched expression.</s><s>Two examples among the uncovered MC "private genes" are T1/ST2 (IL1RL1) and MRGPRX2 <ref type="bibr" target="#b0">[1]</ref>, the former encoding the IL-33 receptor <ref type="bibr" target="#b34">[35]</ref>, the latter a G protein coupled receptor mediating so-called "pseudo-allergic" reactions <ref type="bibr" target="#b35">[36]</ref>.</s><s>Here, we investigated their modulation by RA.</s><s>CD43 (SPN), earlier reported to be an RA-responsive gene in MCs <ref type="bibr" target="#b27">[28,</ref><ref type="bibr" target="#b36">37]</ref>, served as positive control, and was confirmed to also be promoted by RA in the current study (Figure <ref type="figure" target="#fig_8">4A</ref>).</s><s>ST2/T1 as well as MRGPRX2 were robustly expressed by MCs (Figure <ref type="figure" target="#fig_8">4B,C</ref> showing expression against the highly expressed β actin gene) but not by other cell subsets (like dermal fibroblasts and several cell lines, not depicted), substantiating the results from FANTOM5 <ref type="bibr" target="#b0">[1]</ref>.</s><s>T1/ST2 gene expression remained unaffected in the presence of RA (Figure <ref type="figure" target="#fig_8">4B</ref>).</s><s>In contrast, MRGPRX2 expression substantially diminished after RA treatment down to 34.8% (Figure <ref type="figure" target="#fig_8">4C</ref>), thereby duplicating the effect on MC chymase.</s><s>MRGPRX2 is the long-sought receptor for compound 48/80, a typical MC secretagogue able to degranulate MCs of skin origin <ref type="bibr" target="#b35">[36]</ref>.</s><s>We therefore asked whether its decreased expression in RA-treated cells would be mirrored at the functional level.</s><s>This was clearly found to be the case, and compound 48/80-triggered degranulation was reduced by RA pretreatment in each MC preparation tested (Figure <ref type="figure" target="#fig_8">4D</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">Discussion</head><p><s>Vitamin A derivatives such as RA have long been known for their wide-range of effects in embryonic development and tissue homeostasis alike, where retinoid receptors impinge on gene expression programs by binding as heterodimers to retinoic acid response elements in target genes to regulate multiple cellular functions <ref type="bibr" target="#b37">[38]</ref><ref type="bibr" target="#b38">[39]</ref><ref type="bibr" target="#b39">[40]</ref>.</s></p><p><s>RA has a particularly profound impact on skin biology.</s><s>In fact, the skin endogenously produces substantial amounts of RA and its precursors (such as retinol) that contribute to the maintenance of skin homeostasis <ref type="bibr" target="#b15">[16]</ref>, while therapeutically applied retinoids represent approved (topical or oral) treatments for a wide range of skin disorders including psoriasis, acne, photoaging, non-melanoma skin cancer, cutaneous T-cell lymphomas, ichthyosis, as well as chronic hand eczema, and they even form part of cosmetic products <ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref>.</s></p><p><s>So far, the focus of cutaneous RA research was inclined towards keratinocytes and fibroblasts, while cutaneous MCs have not been considered major participants in the retinoid system of the skin.</s><s>Moreover, studies that did focus on the retinoid-MC connection rarely employed MCs of skin origin <ref type="bibr" target="#b36">[37,</ref><ref type="bibr" target="#b40">[41]</ref><ref type="bibr" target="#b41">[42]</ref><ref type="bibr" target="#b42">[43]</ref><ref type="bibr" target="#b43">[44]</ref>.</s><s>However, MC heterogeneity is a well-known phenomenon, where representatives of the lineage display variability across species, tissues, and microenvironments.</s><s>It therefore came as a surprise that a cell, which had received fairly little attention with regard to the cutaneous Vitamin A system, turned out a more important partaker than envisaged thus far <ref type="bibr" target="#b27">[28]</ref>.</s><s>This fostered our interest in the impact imposed by RA on MCs in human skin, complementing earlier reports on RA's modulation of adhesion molecules and selected differentiation markers, performed chiefly on immature MC lines and in vitro generated MC progenitors <ref type="bibr" target="#b36">[37,</ref><ref type="bibr" target="#b40">[41]</ref><ref type="bibr" target="#b41">[42]</ref><ref type="bibr" target="#b42">[43]</ref><ref type="bibr" target="#b43">[44]</ref>.</s></p><p><s>To gain insight into RA's modulatory activity in MCs of skin origin, the current study was designed to investigate a reasonable spectrum of processes, encompassing basic cellular functions (like survival and proliferation), as well as MC-specific programs like granule constituent accumulation and allergic as well as pseudo-allergic MC degranulation, with the result that RA indeed impacts functional competence of skin-derived MCs.</s></p><p><s>We first focused on cell cycle progression and cell viability, two fundamental and tightly regulated processes of every cell subset.</s><s>There is abundant evidence in the literature demonstrating that RA can either enhance or counter mitogenesis depending on cell type and context.</s><s>In our system, a considerable anti-proliferative action of RA was detected by BrdU incorporation, and this was reflected by changes in cell cycle regulators like PCNA and E2F1, both of which associated with the proliferative state of human skin-derived MCs <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b30">31]</ref>.</s><s>In contrast, we did not observe any modulation in p21 expression, a gene frequently up-regulated by RA in a variety of leukemic cells <ref type="bibr" target="#b44">[45,</ref><ref type="bibr" target="#b45">46]</ref>.</s><s>Together, this implies that the mechanisms by which RA inhibits mitogenesis are cell-type specific.</s><s>The anti-proliferative activity detected here for non-transformed skin-derived MCs is consistent with RA-induced cell cycle arrest in leukemia cells, including cells of the human MC line HMC-1 <ref type="bibr" target="#b46">[47,</ref><ref type="bibr" target="#b47">48]</ref>, as well as in hematopoietic progenitor-derived MCs <ref type="bibr" target="#b42">[43,</ref><ref type="bibr" target="#b43">44]</ref>.</s><s>The combined evidence now indicates that RA interference with MC proliferation occurs in a manner that is largely independent of the precise nature of the MCs (leukemic versus normal, slowly or rapidly dividing, tissue or precursor-derived).</s><s>Contrary to the inhibited proliferation, RA had no negative impact on MC survival, where even a modest anti-apoptotic effect was revealed.</s><s>An uncoupling between proliferation and survival, yet in the opposite direction, was previously reported for myeloid progenitors, where increased growth by RA was associated with decreased survival <ref type="bibr" target="#b48">[49]</ref>.</s></p><p><s>Collectively, in cycling MCs, RA will counter cell increments by decelerating cell cycle progression, while under conditions in which no (major) proliferation occurs, the MC compartment will unlikely experience major numerical changes by RA, or else survival will even be enhanced, as was also evidenced in a previous study <ref type="bibr" target="#b43">[44]</ref>.</s></p><p><s>In terms of MC-restricted attributes and processes, one finding was that no conspicuous changes occurred in RA treated MCs on microscopic inspection upon staining with toluidine blue, a MC selective dye (Figure <ref type="figure" target="#fig_1">1G</ref>).</s><s>This applied to cell size and the MC-specific granules alike, suggesting that heparin synthesis and overall granule architecture were preserved in the presence of RA.</s><s>Assessing granule constituents one by one, the finer level of resolution revealed several additional aspects.</s><s>Here, histamine and tryptase abundance remained unchanged, while chymase experienced a robust and selective drop.</s></p><p><s>Considering mRNA and mediator levels simultaneously, we found that while tryptase was resistant to alterations at the activity level, there was significant reduction at the mRNA level.</s><s>The discordance between tryptase mRNA and the corresponding peptidase activity has been observed previously and applies to MCs across donors <ref type="bibr" target="#b12">[13]</ref>, MCs skewed by IL-4 <ref type="bibr" target="#b25">[26]</ref> as well as MCs exposed to IL-33 <ref type="bibr" target="#b49">[50]</ref>.</s><s>The bottom line from the different studies combined is that the predictive value of tryptase mRNA for the active protein is low.</s><s>The current study substantiates this notion.</s><s>In our previous report, histamine levels were positively linked to tryptase activity, suggesting that the amount of histamine in the granule may partially dictate tryptase abundance <ref type="bibr" target="#b12">[13]</ref>.</s><s>This is supported by findings in the mouse, as HDC −/− mice (that do not produce histamine) have profound defects in the accumulation of several MC proteases despite normal mRNA levels <ref type="bibr" target="#b50">[51]</ref>.</s><s>Because histamine levels were unchanged in RA-treated cells, it may be speculated that histamine is the critical component in maintaining the amount of active tryptase.</s></p><p><s>On the other hand, there is better, but far from absolute concordance between mRNA and protein in the case of chymase, where chymase mRNA typically shows the same tendency as chymase activity <ref type="bibr" target="#b12">[13,</ref><ref type="bibr" target="#b25">26]</ref>, and this was also detected here.</s><s>In addition, in our population-based study, chymase activity was also positively associated with histamine abundance (yet the strength of the correlation between histamine and chymase was lower than between histamine and tryptase) <ref type="bibr" target="#b12">[13]</ref>.</s><s>The current data further substantiate that mRNA of these highly lineage-specific traits is a necessary but not sufficient prerequisite for the appearance of the functional peptidase products, and that other variables are important, one of which may be the abundance of histamine.</s><s>Notwithstanding, the chymase gene may serve as a prototypical gene to establish the molecular background by which MCs in the skin acquire their selective MC TC signature and how RA interferes with this process.</s></p><p><s>Our data may also provide some interpretation on a previous study, in which MCs were enumerated in human skin exposed to topical RA treatment for up to six weeks <ref type="bibr" target="#b43">[44]</ref>.</s><s>In that work, Hjertson and colleagues found an increase in MC T ("MCs containing only tryptase") MCs in the skin treated with RA cream (which are virtually absent from the skin under normal conditions), while no increase was found for the chymase containing MC TC subset.</s><s>Our current findings offer an explanation, namely that the de novo appearance of MC T MCs in RA treated skin may result from the down-regulated chymase expression, becoming undetectable to immunohistochemistry.</s><s>The increase in MCs (of the MC T category) after RA treatment implies that RA has a survival-promoting role in MCs embedded in their natural habitat, which would also be compatible with the present study.</s></p><p><s>Addressing RA's impact on the most thoroughly investigated and clinically relevant MC process, i.e., allergic stimulation, the current study revealed that RA unexpectedly, but discernibly promoted degranulation responses triggered by FcεRI cross-linking.</s><s>Of note, there was a simultaneous tendency towards reduced FcεRI expression together with the increased FcεRI functionality.</s><s>This finding adds to the growing appreciation that IgER expression and IgER-triggered degranulation represent uncoupled qualities of MCs ( <ref type="bibr" target="#b12">[13]</ref> and references therein).</s><s>Taken together, RA fosters allergic degranulation by a route independent of enhanced FcεRI expression.</s><s>The process of FcεRI-elicited exocytosis is highly complex and involves not only numerous signaling intermediates, but also a diverse set of accessory proteins which organize traffic, priming, tethering and docking of secretory vesicles, such as members of the Rab, Munc13, and Munc18 families, and especially Ca 2+ sensors like synaptotagmins and other Ca 2+ acceptors <ref type="bibr" target="#b51">[52]</ref>.</s><s>RA may influence several of these molecules in different directions, which would be compatible with the finding that at low cross-linking efficiency, inhibition of FcεRI-elicited exocytosis by RA prevails (Figure <ref type="figure" target="#fig_6">3D</ref>).</s><s>From an allergy-centered view the globally rather increased propensity of RA-exposed MCs to exocytosis implies a pro-allergic role of RA at the level of the skin MC, at least in situations in which specific IgE and allergen are intermediate to abundant.</s></p><p><s>A rather pro-allergic or generally pro-inflammatory function of RA in skin MCs is further supported by our previous observation of strengthened cytokine responses in response to RA <ref type="bibr" target="#b27">[28]</ref>, and earlier studies showing increased expression of adhesion molecules in (mainly leukemic) MCs <ref type="bibr" target="#b36">[37,</ref><ref type="bibr" target="#b40">41,</ref><ref type="bibr" target="#b41">42]</ref>.</s><s>This view also fits the finding of RA-mediated attraction of T cells not only to mucosal tissues but also to inflamed sites, supportive of a rather inflammation-promoting or -maintaining function of RA <ref type="bibr" target="#b52">[53]</ref>.</s><s>Collectively, the combined data imply that the overall effect of RA on skin MCs is highly gene and process-specific.</s><s>While MCs seem to adopt a more inflammatory role in the presence of RA, RA apparently drives MCs away from their cutaneous signature.</s><s>This is based on the finding that RA dampens the "classical" marker of the MC TC subset, i.e., MC chymase.</s><s>In fact, chymase is a strong criterion of skin MC maturity, because other lineage attributes (including FcεRI and HDC) are also expressed in more immature MCs <ref type="bibr" target="#b53">[54]</ref>.</s><s>This may signify a partially dedifferentiating effect of RA on MCs away from the phenotype imprinted by the surrounding dermal compartment.</s><s>In further agreement with this notion, RA has a negative impact on MRGPRX2 expression, the receptor for several neuropeptides as well as pseudo-allergic reactions (the latter triggered by a variety of drugs) <ref type="bibr" target="#b35">[36,</ref><ref type="bibr" target="#b54">55]</ref>.</s><s>In fact, using the MRGPRX2 agonist compound 48/80, we directly demonstrate that RA blunts responses to this MC TC -related G protein coupled receptor, matching RA's impact on MRGPRX2 expression (Figure <ref type="figure" target="#fig_8">4D</ref>).</s><s>Like MC chymase, MRGPRX2 seems to be confined to MCs in skin tissue, as MCs of mucosal tissues, including lung (a prototypical member of the MC T type) lack discernible MRGPRX2 expression <ref type="bibr" target="#b55">[56,</ref><ref type="bibr" target="#b56">57]</ref>.</s></p><p><s>From a degranulation standpoint, our study revealed an opposite effect of RA on the two major routes of MC degranulation, namely the allergic and the pseudo-allergic pathway.</s><s>Through a series of elegant experiments, it was recently reported that the two pathways differ quite profoundly regarding signaling prerequisites, dynamics, and granule characteristics <ref type="bibr" target="#b57">[58]</ref>.</s><s>While IgER-triggered degranulation is delayed and shows a progressive pattern, MRGPRX2-mediated degranulation is rapid and associated with a quick and transient peak of intracellular calcium that is rapidly followed by secretion of individual secretory granules.</s><s>The IgER-elicited pattern depends on IKK-β activation and SNAP23/STX4 complex formation, processes which are implicated in organizing the so-called compound exocytosis, in which several granules fuse together <ref type="bibr" target="#b57">[58]</ref>.</s><s>We show that RA differentially affects the pathways, favoring allergic degranulation via IgER-triggering, while simultaneously inhibiting the pseudo-allergic route.</s></p><p><s>Together, RA has pleiotropic effects on MCs and seems to operate by different routes in the lineage, on one hand by increasing several immune functions, in which MCs participate, but which are not restricted to the lineage, such as generation of pro-inflammatory cytokines <ref type="bibr" target="#b27">[28]</ref>, but on the other by reducing the most specific genes and processes of the skin-associated MC TC type.</s></p><p><s>It may seem counterintuitive that a molecule like RA with its deep connection to skin physiology would counter the expression of MC lineage markers that are skin-specific.</s><s>It is likely, though, that the expression of each biomolecule is a finely tuned process consisting of positive and negative regulatory circuits.</s><s>So, even though the skin habitat does provide a MC TC -friendly environment, RA may constitute a counter-balancing regulator in this setting.</s><s>Of note, both chymase and MRGPRX2 are still expressed in skin-derived MCs even after exposure to an RA-rich microenvironment, while they are entirely absent from the mucosa of the intestinal and respiratory tract, respectively.</s><s>It therefore seems unlikely that the lack of MC TC marker expression in mucosal tissues primarily stems from the presence of RA (even though RA plays a critical role in mucosal immunity and can redirect immune cells to the gut <ref type="bibr" target="#b52">[53,</ref><ref type="bibr" target="#b58">59]</ref>), but rather that the constellation of transcription factors and epigenetic attributes may be favorable in the skin over mucosal tissues to permit chymase and MRGPRX2 transcription in the first place.</s><s>Revealing the molecular prerequisites behind MC TC specific features is actually an important future challenge in the MC field, and the observations made in this study may actually help in identifying the mechanistic details.</s></p><p><s>Other important future directions will include the dissection of RA-mediated responses in skin MCs in different microenvironments, which by themselves shift MC phenotypes (e.g., IL-4 and IL-33 <ref type="bibr" target="#b25">[26,</ref><ref type="bibr" target="#b49">50]</ref>), because it is clear from studies on hematopoietic stem cells that diverse and even opposing effects can occur in dependence of the growth factors present <ref type="bibr" target="#b37">[38,</ref><ref type="bibr" target="#b48">49]</ref>.</s><s>Of note, the adaptive immune system is under substantial influence from RA.</s><s>For example, RA can skew T helper cell subsets, in particular by supporting Foxp3+ regulatory T cell populations, while simultaneously suppressing Th17 cells <ref type="bibr" target="#b52">[53,</ref><ref type="bibr" target="#b58">59]</ref>, and RA imprints gut homing in these subsets <ref type="bibr" target="#b52">[53,</ref><ref type="bibr" target="#b58">59]</ref>.</s><s>RA can also modify Th1/Th2 subsets <ref type="bibr" target="#b52">[53]</ref>, and impact on B cell mediated immunity by fostering antibody-secreting cells producing the IgA isotype <ref type="bibr" target="#b59">[60]</ref>.</s><s>Considering that MCs interact with T cells and are influenced by their cytokines, MCs in the skin may not only be influenced directly (as is the focus of the current report), but also indirectly via RA's effects on the adaptive immune system.</s><s>It will therefore be of quite some interest to study the effect of RA on MCs embedded in skin equivalents like the organotypic co-culture skin model developed and refined by our group over many years <ref type="bibr" target="#b60">[61,</ref><ref type="bibr" target="#b61">62]</ref> to comprehend RA's role in MC communication with other resident skin cells (fibroblasts, keratinocytes), as well as other immune constituents like T cells.</s></p><p><s>While the complexity of RA activity in the stem cell compartment has been recognized and cataloged <ref type="bibr" target="#b37">[38]</ref>, we are at the beginning of dissecting RA's impact on the MC lineage, a cell enriched with retinoid network components <ref type="bibr" target="#b27">[28]</ref> that shares features with hematopoietic stem cells <ref type="bibr" target="#b0">[1]</ref>.</s><s>The current study provides further evidence that MCs are indeed relevant targets of the retinoid network and should be considered in research of cutaneous retinoid biology.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">Experimental Section</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.1.">Isolation and Culture of Human Skin MCs</head><p><s>MCs were isolated from human breast skin as described <ref type="bibr" target="#b24">[25]</ref> with slight modifications given in recent publications <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b30">31,</ref><ref type="bibr" target="#b62">63]</ref>.</s><s>The skin was obtained from cosmetic breast reduction surgeries, with the informed consent of the patients and approval by the university ethics committee.</s><s>The experiments were conducted according to the Declaration of Helsinki Principles.</s><s>Skin-derived MCs were expanded in basal Iscove's Medium (with 10% FCS, 100 U/mL Penicillin, 100 µg/mL Streptomycin, 2 mM L-Glutamine, 1% nonessential amino acid solution, all from Biochrom, Berlin, Germany), and stem cell factor (SCF) at 100 ng/mL (Peprotech, Hamburg, Germany), as described <ref type="bibr" target="#b25">[26]</ref>, as a modification of a previously published procedure <ref type="bibr" target="#b29">[30]</ref>.</s><s>The cells were used for the experiments described herein after 3-5 weeks, i.e., at a stage when proliferation is detectable in MCs from all donors <ref type="bibr" target="#b30">[31]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.2.">MC Treatment</head><p><s>MCs were kept at 5 × 10 5 /mL in the presence or absence of RA (Sigma-Aldrich, Taufkirchen, Germany) at 100 nM for a total of 7 days.</s><s>RA was provided on days 0, 2, and 4, while SCF (100 ng/mL) was provided on days 0 and 4 to maintain optimal growth, proliferation, and survival.</s><s>MCs were automatically counted by the CASY-TTC and their mean diameter was recorded (Innovatis/Casy Technology, Reutlingen, Germany) <ref type="bibr" target="#b25">[26,</ref><ref type="bibr" target="#b30">31,</ref><ref type="bibr" target="#b62">63]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.3.">Toluidine-Blue Staining and Microscopy</head><p><s>MC granules were specifically stained with acidic toluidine-blue (0.1% in 0.5 N HCl), and stained MCs were photographed using a Zeiss Axiovert 10 microscope and a Canon power shot-A620 digital camera, as described <ref type="bibr" target="#b30">[31,</ref><ref type="bibr" target="#b62">63]</ref>.</s><s>The original magnification was 400×.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.4.">Annexin-FITC/PI Staining</head><p><s>MCs were stained by the Annexin V-FITC Apoptosis detection kit (eBioscience, San Diego, CA, USA) according to the manufacturer's instructions and then analyzed by flow-cytometry on a Facscalibur flow-cytometer device (BD Biosciences, Heidelberg, Germany).</s><s>Annexin-V/PI-double-negative cells were considered alive, while Annexin-V-positive cells were considered apoptotic (Annexin-V-single positive-early apoptotic; Annexin-V-/PI-double positive-late apoptotic), as per instructions.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.5.">BrdU Incorporation</head><p><s>DNA duplication was assessed with the BrdU flow kit (BD Pharmingen, Heidelberg, Germany) according to the vendor's instructions and as described previously for skin-derived MCs <ref type="bibr" target="#b29">[30,</ref><ref type="bibr" target="#b30">31]</ref>.</s><s>In brief, MCs were kept in the presence (or absence for control) of 10 µM BrdU for 5 days prior to harvest and assayed for incorporation of BrdU using anti-BrdU-FITC and flow-cytometry.</s><s>RT-qPCR was performed using optimized conditions and primer pairs described elsewhere <ref type="bibr" target="#b12">[13,</ref><ref type="bibr" target="#b30">31,</ref><ref type="bibr" target="#b63">64]</ref>.</s><s>Values were normalized to the housekeeping gene β-actin.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.7.">FcεRI Surface Expression</head><p><s>Flow-cytometry was performed as described <ref type="bibr" target="#b12">[13,</ref><ref type="bibr" target="#b30">31]</ref>.</s><s>The antibody used was anti-human FcεRIα-PE at 2.5 µg/mL (clone AER-37, eBioscience, San Diego, CA, USA); mouse IgG2b-PE (clone eBWG2b, eBioscience) served as isotype control.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.8.">Histamine Quantitation</head><p><s>Histamine was quantitated by an automated fluorescence method using an autoanalyzer (Borgwald Technik, Hamburg, Germany), exactly as described <ref type="bibr" target="#b12">[13,</ref><ref type="bibr" target="#b30">31]</ref>.</s><s>All determinations were performed in triplicate and histamine concentrations were calculated with reference to a standard curve.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.9.">Histamine Release Assay</head><p><s>MCs were tested for degranulation responses (histamine release) following FcεRI-aggregation (using the anti-FcεRIα-Ab 29C6 at 0.25 µg/mL for single-dose or 0.005, 0.05 and 0.5 µg/mL for the dose-response experiments), compound 48/80 at 10 µg/mL (Sigma-Aldrich) or no stimulus for spontaneous release.</s><s>The assays were performed exactly as described and the net histamine release (%) was calculated as [(stimulated release − spontaneous release)/complete histamine present in the MC preparation] × 100 <ref type="bibr" target="#b12">[13,</ref><ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b30">31]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.10.">MC Protease Activity</head><p><s>Tryptase and chymase activities were quantified according to our routine protocols <ref type="bibr" target="#b12">[13,</ref><ref type="bibr" target="#b30">31,</ref><ref type="bibr" target="#b53">54]</ref> established upon previous publications <ref type="bibr" target="#b64">[65]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.11.">Statistics</head><p><s>Differences between groups were assessed by paired or ratio paired t-test, or (when not normally distributed) by Wilcoxon matched-pairs signed rank test with the program GraphPad-Prism, San Diego, CA, USA.</s><s>p &lt; 0.05 was considered statistically significant.</s><s>The number of independent experiments performed for each assay is given in the respective figure legends as n.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.">Conclusions</head><p><s>The study supports the theory that MCs in human skin are highly relevant targets of Vitamin A metabolites and that RA executes a program in these cells that is oriented towards more general pan-hematopoietic and inflammatory programs while minimizing processes selective for the MC TC subset that prevails in human skin.</s><s>We expect that transcriptional and functional programs of MCs may experience other profound modulations by RA, calling for a need of further research in the future.</s><s>Given that retinoids act as important developmental switches, and that retinoid receptors regulate a plethora of genes, the accumulation of retinoid network components in MCs, as recently revealed <ref type="bibr" target="#b27">[28]</ref>, is of relevance to fields as diverse as vitamin A research, MC biology, and skin (patho-)physiology alike.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s><s>Retinoic acid (RA) inhibits cell cycle progression of skin-derived mast cells (MCs), but also modestly interferes with cell death.</s><s>Cultured skin-derived MCs (at the proliferative stage) were treated with RA as described in the Experimental section and harvested after 7 days.</s><s>(A) Increase in MC numbers (relative to day 0) in the presence versus absence of RA in a variety of donors, indicated by interconnected dots (n = 17); (B) Annexin + cells (in % of total cells) after culture with and without RA, mean ± SEM, n = 5; (C) Expression of apoptosis related genes in RA treated cells normalized to the "no RA" control, mean ± SEM, n = 9, dotted line drawn at 1 to highlight control expression (in the absence of RA); (D,E) BrdU incorporation (added 5 days before harvest), as determined by flow-cytometry, (D) representative example, (E) mean ± SEM of n = 7; (F) Expression of cell cycle associated genes in RA treated cells normalized to the "no RA" control, mean ± SEM, n = 9; (G) Visualization of MCs upon acidic toluidine blue staining reveals no conspicuous changes by RA; note the bright purple granules and the accumulation of cytoplasm, the latter typical of MCs exposed to SCF; (A,B,E) Paired t-test, (C,F) one-sample t-test versus control (set as 1).</s><s>* p &lt; 0.05; ** p &lt; 0.01, *** p &lt; 0.001, **** p &lt; 0.0001 versus control.</s></p></div></figDesc><graphic coords="3,110.96,251.37,70.42,74.36" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Fig 1</s></p></div></figDesc><graphic coords="3,433.03,227.34,50.97,84.16" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 2 .</head><label>2</label><figDesc><div><p><s>Figure 2. Granule-associated mediators: RA dampens chymase mRNA and chymase activity.</s><s>(A) Relative mRNA expression of histidine decarboxylase (HDC, involved in histamine generation), tryptase and chymase normalized to β actin, respectively, in RA treated and control cells (mean ± SEM, n = 9); (B) Mediator contents.</s><s>Histamine was quantified by an auto-analyzer based method, while tryptase and chymase activity were measured by cleavage of specific substrates in RA pretreated and control cells, as described in the Experimental section.</s><s>Each dot corresponds to one MC preparation and dots representing the same donor are connected.</s><s>n = 11 (histamine) or 9 (tryptase, chymase).</s><s>** p &lt; 0.01, *** p &lt; 0.001 versus control (by paired t-test).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 2 .</head><label>2</label><figDesc><div><p><s>Figure 2. Granule-associated mediators: RA dampens chymase mRNA and chymase activity.</s><s>(A) Relative mRNA expression of histidine decarboxylase (HDC, involved in histamine generation), tryptase and chymase normalized to β actin, respectively, in RA treated and control cells (mean ± SEM, n = 9); (B) Mediator contents.</s><s>Histamine was quantified by an auto-analyzer based method, while tryptase and chymase activity were measured by cleavage of specific substrates in RA pretreated and control cells, as described in the Experimental section.</s><s>Each dot corresponds to one MC preparation and dots representing the same donor are connected.</s><s>n = 11 (histamine) or 9 (tryptase, chymase).</s><s>** p &lt; 0.01, *** p &lt; 0.001 versus control (by paired t-test).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head></head><label></label><figDesc><div><p><s>Int. J. Mol.</s><s>Sci.</s><s>2017, 18, 525 5 of 15</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Figure 3 .</head><label>3</label><figDesc><div><p><s>Figure 3. RA reinforces FcεRI-mediated degranulation, but has no effect on the expression of the FcεRI receptor complex.</s><s>(A,B) FcεRI cell surface expression by flow-cytometry; (A) Representative example, (B) cumulative data from n = 8 MC preparations; MFI = Mean fluorescence intensity; (C) Left, Histamine release in the absence of a specific stimulus (spontaneous) in % of the complete cellular histamine present in the respective MC preparation; right, net histamine release specifically elicited by FcεRI-aggregation (note that spontaneous release, determined for each preparation, was subtracted from the corresponding value after FcεRI-triggering) in RA pretreated and control MCs.</s><s>n = 14; (B,C) Each dot corresponds to one MC preparation and dots representing the same donor are connected; (D) Dose-response of histamine release in RA pretreated and control cells triggered by different concentrations of the IgER-aggregating antibody 29C6, experiment as in (C) but using another set of MC preparations and other concentrations, n = 7. (E) Relative mRNA expression of the three chains forming the FcεRI complex normalized to β actin (mean ± SEM, n = 9).</s><s>* p &lt; 0.05, ** p &lt; 0.01, **** p &lt; 0.0001 significantly higher than control, + p &lt; 0.05 significantly lower than control; ns = not significant.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Figure 3 .</head><label>3</label><figDesc><div><p><s>Fig 3</s></p></div></figDesc><graphic coords="5,113.84,306.54,55.08,64.04" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head>Figure 4 .</head><label>4</label><figDesc><div><p><s>Figure 4. Impact of RA on other genes and MC-restricted processes.</s><s>Relative mRNA expression, normalized to β actin, for (A) the pan-hematopoietic sialoprotein CD43 (the latter used as control of an RA-upregulated gene); (B) the IL-33 receptor ST2/T1, and (C) the MC-selective receptor MRGPRX2, Mean ± SEM, n = 9; (D) net histamine release elicited by MRGPRX2 triggering (by use of its agonist compound 48/80 at 10 μg/mL) in RA pretreated and control MCs (analogous to Figure 3C,D).</s><s>n = 12.</s><s>Each dot corresponds to one MC preparation and dots representing the same donor are connected.</s><s>** p &lt; 0.01, *** p &lt; 0.001, **** p &lt; 0.0001 significantly different from control (by paired t-test); ns = not significant.</s></p></div></figDesc><graphic coords="6,120.87,397.39,340.14,234.00" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_8"><head>Figure 4 .</head><label>4</label><figDesc><div><p><s>Figure 4. Impact of RA on other genes and MC-restricted processes.</s><s>Relative mRNA expression, normalized to β actin, for (A) the pan-hematopoietic sialoprotein CD43 (the latter used as control of an RA-upregulated gene); (B) the IL-33 receptor ST2/T1, and (C) the MC-selective receptor MRGPRX2, Mean ± SEM, n = 9; (D) net histamine release elicited by MRGPRX2 triggering (by use of its agonist compound 48/80 at 10 µg/mL) in RA pretreated and control MCs (analogous to Figure 3C,D).</s><s>n = 12.</s><s>Each dot corresponds to one MC preparation and dots representing the same donor are connected.</s><s>** p &lt; 0.01, *** p &lt; 0.001, **** p &lt; 0.0001 significantly different from control (by paired t-test); ns = not significant.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_9"><head>4. 6 .</head><label>6</label><figDesc><div><p><s>Reverse Transcription-Quantitative PCR (RT-qPCR)</s></p></div></figDesc></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Int. J. Mol. Sci. 2017,<ref type="bibr" target="#b17">18</ref>, 525; doi:10.3390/ijms18030525 www.mdpi.com/journal/ijms</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0" />
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Author Contributions: Magda Babina conceived the study, analyzed and interpreted the data, and wrote the manuscript; Metin Artuc and Sven Guhl performed experiments; Torsten Zuberbier helped with study design and revised the manuscript.</s><s>All authors approved the final version of the manuscript.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflicts of Interest:</head><p><s>The authors declare no conflict of interest.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Redefinition of the human mast cell transcriptome by deep-CAGE sequencing</title>
		<author>
			<persName><forename type="first">E</forename><surname>Motakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Guhl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ishizu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Itoh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kawaji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>De Hoon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Lassmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Carninci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hayashizaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Zuberbier</surname></persName>
		</author>
		<idno type="DOI">10.1182/blood-2013-02-483792</idno>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="page" from="e58" to="e67" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Mast cell transcriptome elucidation: What are the implications for allergic disease in the clinic and where do we go next?</title>
		<author>
			<persName><forename type="first">M</forename><surname>Babina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Motakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Zuberbier</surname></persName>
		</author>
		<idno type="DOI">10.1586/1744666X.2014.933074</idno>
	</analytic>
	<monogr>
		<title level="j">Expert Rev. Clin. Immunol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="977" to="980" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Development of mast cells</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Kitamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Oboki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ito</surname></persName>
		</author>
		<idno type="DOI">10.2183/pjab.83.164</idno>
	</analytic>
	<monogr>
		<title level="j">Proc. Jpn. Acad. Ser. B Phys. Biol. Sci</title>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="page" from="164" to="174" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Mast cells and mastocytosis</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Metcalfe</surname></persName>
		</author>
		<idno type="DOI">10.1182/blood-2007-11-078097</idno>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page" from="946" to="956" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Regulation of mast cell responses in health and disease</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Gilfillan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Beaven</surname></persName>
		</author>
		<idno type="DOI">10.1615/CritRevImmunol.v31.i6.30</idno>
	</analytic>
	<monogr>
		<title level="j">Crit. Rev. Immunol</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="475" to="529" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">The mast cell and allergic diseases: Role in pathogenesis and implications for therapy</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Metcalfe</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1365-2222.2007.02886.x</idno>
	</analytic>
	<monogr>
		<title level="j">Clin. Exp. Allergy</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="4" to="18" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">What causes itch in atopic dermatitis? Curr</title>
		<author>
			<persName><forename type="first">G</forename><surname>Yosipovitch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Papoiu</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11882-008-0049-z</idno>
	</analytic>
	<monogr>
		<title level="j">Allergy Asthma Rep</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="306" to="311" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">IgE and mast cells in allergic disease</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Galli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tsai</surname></persName>
		</author>
		<idno type="DOI">10.1038/nm.2755</idno>
	</analytic>
	<monogr>
		<title level="j">Nat. Med</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="693" to="704" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Mast cells in atopic dermatitis</title>
		<author>
			<persName><forename type="first">T</forename><surname>Kawakami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ando</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kimura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kawakami</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.coi.2009.09.006</idno>
	</analytic>
	<monogr>
		<title level="j">Curr. Opin. Immunol</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="666" to="678" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Is there a role for mast cells in psoriasis?</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">T</forename><surname>Harvima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Nilsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Suttle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Naukkarinen</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00403-008-0874-x</idno>
	</analytic>
	<monogr>
		<title level="j">Arch. Dermatol. Res</title>
		<imprint>
			<biblScope unit="volume">300</biblScope>
			<biblScope unit="page" from="461" to="478" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Progress and challenges in the understanding of chronic urticaria</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ferrer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Kaplan</surname></persName>
		</author>
		<idno type="DOI">10.1186/1710-1492-3-1-31</idno>
	</analytic>
	<monogr>
		<title level="j">Allergy Asthma Clin. Immunol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="31" to="35" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Anaphylaxis with clonal mast cells in normal looking skin-A new entity?</title>
		<author>
			<persName><forename type="first">A</forename><surname>Bretterklieber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Beham-Schmid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Sturm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Berghold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Brezinschek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Aberer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Aberer</surname></persName>
		</author>
		<idno type="DOI">10.1111/all.12634</idno>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page" from="864" to="872" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Phenotypic variability in human skin mast cells</title>
		<author>
			<persName><forename type="first">M</forename><surname>Babina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Guhl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Artuc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">N</forename><surname>Trivedi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Zuberbier</surname></persName>
		</author>
		<idno type="DOI">10.1111/exd.12924</idno>
	</analytic>
	<monogr>
		<title level="j">Exp. Dermatol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="434" to="439" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Immunological Genome Project Consortium. Expression profiling of constitutive mast cells reveals a unique identity within the immune system</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Dwyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Barrett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">F</forename><surname>Austen</surname></persName>
		</author>
		<idno type="DOI">10.1038/ni.3445</idno>
	</analytic>
	<monogr>
		<title level="j">Nat. Immunol</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="878" to="887" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Molecular mechanisms of retinoid actions in skin</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Fisher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Voorhees</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FASEB J</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="1002" to="1013" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Decreased retinoid concentration and retinoid signalling pathways in human atopic dermatitis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Mihaly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gamlieli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Worm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ruhl</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1600-0625.2010.01225.x</idno>
	</analytic>
	<monogr>
		<title level="j">Exp. Dermatol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="326" to="330" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Molecular mechanisms of intrinsic skin aging and retinoid-induced repair and reversal</title>
		<author>
			<persName><forename type="first">J</forename><surname>Varani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Fisher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Voorhees</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Investig. Dermatol. Symp. Proc</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="57" to="60" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Retinoid therapy: Compatible skin care</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Appa</surname></persName>
		</author>
		<idno type="DOI">10.1159/000029864</idno>
	</analytic>
	<monogr>
		<title level="j">Skin Pharmacol. Appl. Skin Physiol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="111" to="119" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Systemic and topical retinoids in the management of skin cancer in organ transplant recipients</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">G</forename><surname>De Graaf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Euvrard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Bouwes Bavinck</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Dermatol. Surg</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="656" to="661" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Treatment of cutaneous T-cell lymphoma with retinoids</title>
		<author>
			<persName><forename type="first">C</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Duvic</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1529-8019.2006.00083.x</idno>
	</analytic>
	<monogr>
		<title level="j">Dermatol. Ther</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="264" to="271" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">A review of acitretin for the treatment of psoriasis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Li</surname></persName>
		</author>
		<idno type="DOI">10.1517/14740330903393732</idno>
	</analytic>
	<monogr>
		<title level="j">Expert Opin. Drug Saf</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="769" to="779" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Systemic retinoids in the management of ichthyoses and related skin types</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Digiovanna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Mauro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Milstone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schmuth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Toro</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1529-8019.2012.01527.x</idno>
	</analytic>
	<monogr>
		<title level="j">Dermatol. Ther</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="26" to="38" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Retinoids in the treatment of skin aging: An overview of clinical efficacy and safety</title>
		<author>
			<persName><forename type="first">S</forename><surname>Mukherjee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Date</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Patravale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Korting</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Roeder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Weindl</surname></persName>
		</author>
		<idno type="DOI">10.2147/ciia.2006.1.4.327</idno>
	</analytic>
	<monogr>
		<title level="j">Clin. Interv. Aging</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="327" to="348" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Impact of systemic alitretinoin treatment on skin barrier gene and protein expression in patients with chronic hand eczema</title>
		<author>
			<persName><forename type="first">V</forename><surname>Kumari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Timm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Kuhl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Heine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Worm</surname></persName>
		</author>
		<idno type="DOI">10.1111/bjd.14921</idno>
	</analytic>
	<monogr>
		<title level="j">Br. J. Dermatol</title>
		<imprint>
			<biblScope unit="volume">175</biblScope>
			<biblScope unit="page" from="1243" to="1250" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Comparative cytokine profile of human skin mast cells from two compartments-Strong resemblance with monocytes at baseline but induction of IL-5 by IL-4 priming</title>
		<author>
			<persName><forename type="first">M</forename><surname>Babina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Guhl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Starke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Kirchhof</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Zuberbier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Henz</surname></persName>
		</author>
		<idno type="DOI">10.1189/jlb.0403157</idno>
	</analytic>
	<monogr>
		<title level="j">J. Leukoc. Biol</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="page" from="244" to="252" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">IL-4 and human skin mast cells revisited: Reinforcement of a pro-allergic phenotype upon prolonged exposure</title>
		<author>
			<persName><forename type="first">M</forename><surname>Babina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Guhl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Artuc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Zuberbier</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00403-016-1688-x</idno>
	</analytic>
	<monogr>
		<title level="j">Arch. Dermatol. Res</title>
		<imprint>
			<biblScope unit="volume">308</biblScope>
			<biblScope unit="page" from="665" to="670" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">A promoter-level mammalian expression atlas</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Forrest</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kawaji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rehli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Baillie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J L</forename><surname>De Hoon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Haberle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Lassmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">V</forename><surname>Kulakovskiy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lizio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Itoh</surname></persName>
		</author>
		<idno type="DOI">10.1038/nature13182</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">507</biblScope>
			<biblScope unit="page" from="462" to="470" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Retinoic acid potentiates inflammatory cytokines in human mast cells: Identification of mast cells as prominent constituents of the skin retinoid network</title>
		<author>
			<persName><forename type="first">M</forename><surname>Babina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Guhl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Motakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Artuc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hazzan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Worm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Forrest</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Zuberbier</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.mce.2015.02.019</idno>
	</analytic>
	<monogr>
		<title level="j">Mol. Cell. Endocrinol</title>
		<imprint>
			<biblScope unit="volume">406</biblScope>
			<biblScope unit="page" from="49" to="59" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells</title>
		<author>
			<persName><forename type="first">E</forename><surname>Arner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">O</forename><surname>Daub</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Vitting-Seerup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Andersson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lilje</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Drablos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lennartsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ronnerblad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Hrydziuszko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Vitezic</surname></persName>
		</author>
		<idno type="DOI">10.1126/science.1259418</idno>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">347</biblScope>
			<biblScope unit="page" from="1010" to="1014" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Long-term cultured human skin mast cells are suitable for pharmacological studies of anti-allergic drugs due to high responsiveness to fcepsilonri cross-linking</title>
		<author>
			<persName><forename type="first">S</forename><surname>Guhl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Artuc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Neou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Babina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Zuberbier</surname></persName>
		</author>
		<idno type="DOI">10.1271/bbb.100745</idno>
	</analytic>
	<monogr>
		<title level="j">Biosci. Biotechnol. Biochem</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="page" from="382" to="384" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Skin mast cells develop non-synchronized changes in typical lineage characteristics upon culture</title>
		<author>
			<persName><forename type="first">S</forename><surname>Guhl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Neou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Artuc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Zuberbier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Babina</surname></persName>
		</author>
		<idno type="DOI">10.1111/exd.12558</idno>
	</analytic>
	<monogr>
		<title level="j">Exp. Dermatol</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="933" to="935" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Mast cell tryptases and chymases in inflammation and host defense</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">H</forename><surname>Caughey</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1600-065X.2007.00509.x</idno>
	</analytic>
	<monogr>
		<title level="j">Immunol. Rev</title>
		<imprint>
			<biblScope unit="volume">217</biblScope>
			<biblScope unit="page" from="141" to="154" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Mast cell proteases</title>
		<author>
			<persName><forename type="first">G</forename><surname>Pejler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Abrink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ringvall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wernersson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adv. Immunol</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="167" to="255" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Current concepts of IgE regulation and impact of genetic determinants</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Potaczek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kabesch</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1365-2222.2011.03953.x</idno>
	</analytic>
	<monogr>
		<title level="j">Clin. Exp. Allergy</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="852" to="871" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">IL-33 and thymic stromal lymphopoietin in mast cell functions</title>
		<author>
			<persName><forename type="first">R</forename><surname>Saluja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Zoltowska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Ketelaar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Nilsson</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ejphar.2015.04.047</idno>
	</analytic>
	<monogr>
		<title level="j">Eur. J. Pharmacol</title>
		<imprint>
			<biblScope unit="volume">778</biblScope>
			<biblScope unit="page" from="68" to="76" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Mcneil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Pundir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Meeker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Undem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kulka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Dong</surname></persName>
		</author>
		<idno type="DOI">10.1038/nature14022</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">519</biblScope>
			<biblScope unit="page" from="237" to="241" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Cd43 (leukosialin, sialophorin) expression is differentially regulated by retinoic acids</title>
		<author>
			<persName><forename type="first">M</forename><surname>Babina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Weber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Henz</surname></persName>
		</author>
		<idno type="DOI">10.1002/eji.1830270515</idno>
	</analytic>
	<monogr>
		<title level="j">Eur. J. Immunol</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="1147" to="1151" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Roles of retinoids and retinoic acid receptors in the regulation of hematopoietic stem cell self-renewal and differentiation</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Purton</surname></persName>
		</author>
		<idno type="DOI">10.1155/2007/87934</idno>
	</analytic>
	<monogr>
		<title level="j">PPAR Res</title>
		<imprint>
			<biblScope unit="volume">87934</biblScope>
			<date type="published" when="2007">2007. 2007</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Dynamic and combinatorial control of gene expression by nuclear retinoic acid receptors (RARs)</title>
		<author>
			<persName><forename type="first">C</forename><surname>Rochette-Egly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Germain</surname></persName>
		</author>
		<idno type="DOI">10.1621/nrs.07005</idno>
	</analytic>
	<monogr>
		<title level="j">Nucl. Recept. Signal</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>e005. [CrossRef. PubMed</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Retinoids regulate stem cell differentiation</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Gudas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Wagner</surname></persName>
		</author>
		<idno type="DOI">10.1002/jcp.22417</idno>
	</analytic>
	<monogr>
		<title level="j">J. Cell. Physiol</title>
		<imprint>
			<biblScope unit="volume">226</biblScope>
			<biblScope unit="page" from="322" to="330" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Retinoic acids and dexamethasone alter cell-surface density of β2-integrins and ICAM-1 on human leukemic (HMC-1) mast cells</title>
		<author>
			<persName><forename type="first">M</forename><surname>Babina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Weber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Henz</surname></persName>
		</author>
		<idno type="DOI">10.1007/s004030050164</idno>
	</analytic>
	<monogr>
		<title level="j">Arch. Dermatol. Res</title>
		<imprint>
			<biblScope unit="volume">289</biblScope>
			<biblScope unit="page" from="111" to="115" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Retinoic acid up-regulates myeloid ICAM-3 expression and function in a cell-specific fashion-Evidence for retinoid signaling pathways in the mast cell lineage</title>
		<author>
			<persName><forename type="first">M</forename><surname>Babina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mammeri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Henz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Leukoc. Biol</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="361" to="372" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Retinoic acid is a negative regulator for the differentiation of cord blood-derived human mast cell progenitors</title>
		<author>
			<persName><forename type="first">T</forename><surname>Kinoshita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Koike</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Mwamtemi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ishida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Nakazawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kurokawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sakashita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Higuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Takeuchi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="2821" to="2828" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Retinoic acid inhibits in vitro development of mast cells but has no marked effect on mature human skin tryptase-and chymase-positive mast cells</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hjertson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Kivinen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Dimberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Nilsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">T</forename><surname>Harvima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Nilsson</surname></persName>
		</author>
		<idno type="DOI">10.1046/j.1523-1747.2003.12030.x</idno>
	</analytic>
	<monogr>
		<title level="j">J. Investig. Dermatol</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="page" from="239" to="245" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Transcriptional activation of the human p21(WAF1/CIP1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation</title>
		<author>
			<persName><forename type="first">M</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Iavarone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">P</forename><surname>Freedman</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.271.49.31723</idno>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">271</biblScope>
			<biblScope unit="page" from="31723" to="31728" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Inhibition of myeloma cell growth by all-trans retinoic acid is associated with upregulation of p21WAF1 and dephosphorylation of the retinoblastoma protein</title>
		<author>
			<persName><forename type="first">D</forename><surname>Lavelle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">H</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hankewych</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Desimone</surname></persName>
		</author>
		<idno type="DOI">10.3109/10428199909145729</idno>
	</analytic>
	<monogr>
		<title level="j">Leuk. Lymphoma</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="261" to="268" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Inhibitory effect of retinoic acid on proliferation, maturation and tryptase level in human leukemic mast cells (HMC-1)</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Alexandrakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Kyriakou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Seretakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Boucher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Letourneau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kempuraj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">C</forename><surname>Theoharides</surname></persName>
		</author>
		<idno type="DOI">10.1177/039463200301600106</idno>
	</analytic>
	<monogr>
		<title level="j">Int. J. Immunopathol. Pharmacol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="43" to="47" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Phenotypic characterization of the human mast-cell line HMC-1</title>
		<author>
			<persName><forename type="first">G</forename><surname>Nilsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Blom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kusche-Gullberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Kjellen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Butterfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sundstrom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Nilsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Hellman</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1365-3083.1994.tb03404.x</idno>
	</analytic>
	<monogr>
		<title level="j">Scand. J. Immunol</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="489" to="498" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">All-trans-retinoic acid effects the growth, differentiation and apoptosis of normal human myeloid progenitors derived from purified CD34+ bone marrow cells</title>
		<author>
			<persName><forename type="first">D</forename><surname>Douer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ramezani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Parker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Levine</surname></persName>
		</author>
		<idno type="DOI">10.1038/sj.leu.2401772</idno>
	</analytic>
	<monogr>
		<title level="j">Leukemia</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="874" to="881" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b49">
	<monogr>
		<title level="m" type="main">The yin and yang of IL-33 in human skin mast cell biology-Reinforcement of proliferation and histamine synthesis combined with profound decline in immunological and non-immunological histamine releasability</title>
		<author>
			<persName><forename type="first">M</forename><surname>Babina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Guhl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Artuc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Zuberbier</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note>in preparation</note>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Mice lacking histidine decarboxylase exhibit abnormal mast cells</title>
		<author>
			<persName><forename type="first">H</forename><surname>Ohtsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tanaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Terui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Makabe-Kobayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Pejler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Tchougounova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Hellman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gertsenstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Hirasawa</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0014-5793(01)02663-1</idno>
	</analytic>
	<monogr>
		<title level="j">FEBS Lett</title>
		<imprint>
			<biblScope unit="volume">502</biblScope>
			<biblScope unit="page" from="53" to="56" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Vesicular trafficking and signaling for cytokine and chemokine secretion in mast cells</title>
		<author>
			<persName><forename type="first">U</forename><surname>Blank</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">K</forename><surname>Madera-Salcedo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Danelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Claver</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Tiwari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sánchez-Miranda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Vázquez-Victorio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Ramírez-Valadez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Macias-Silva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>González-Espinosa</surname></persName>
		</author>
		<idno type="DOI">10.3389/fimmu.2014.00453</idno>
	</analytic>
	<monogr>
		<title level="j">Front. Immunol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Retinoic acid as a modulator of T cell immunity</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Bono</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Tejon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Flores-Santibañez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Fernandez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rosemblatt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Sauma</surname></persName>
		</author>
		<idno type="DOI">10.3390/nu8060349</idno>
	</analytic>
	<monogr>
		<title level="j">Nutrients</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">E349</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Mast cell lines HMC-1 and LAD2 in comparison with mature human skin mast cells-Drastically reduced levels of tryptase and chymase in mast cell lines</title>
		<author>
			<persName><forename type="first">S</forename><surname>Guhl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Babina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Neou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Zuberbier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Artuc</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1600-0625.2010.01103.x</idno>
	</analytic>
	<monogr>
		<title level="j">Exp. Dermatol</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="845" to="847" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Immunoglobulin E-independent activation of mast cell is mediated by mrg receptors</title>
		<author>
			<persName><forename type="first">K</forename><surname>Tatemoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Nozaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Tsuda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Konno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tomura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Furuno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ogasawara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Edamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Takagi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Iwamura</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bbrc.2006.08.177</idno>
	</analytic>
	<monogr>
		<title level="j">Biochem. Biophys. Res. Commun</title>
		<imprint>
			<biblScope unit="volume">349</biblScope>
			<biblScope unit="page" from="1322" to="1328" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Expression of mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria</title>
		<author>
			<persName><forename type="first">D</forename><surname>Fujisawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kashiwakura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kikukawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Fujitani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Sasaki-Sakamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kuroda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nunomura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hayama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Terui</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jaci.2014.05.004</idno>
	</analytic>
	<monogr>
		<title level="j">J. Allergy Clin. Immunol</title>
		<imprint>
			<biblScope unit="volume">134</biblScope>
			<biblScope unit="page" from="622" to="633" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases</title>
		<author>
			<persName><forename type="first">H</forename><surname>Subramanian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Gupta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ali</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jaci.2016.04.051</idno>
	</analytic>
	<monogr>
		<title level="j">J. Allergy Clin. Immunol</title>
		<imprint>
			<biblScope unit="volume">138</biblScope>
			<biblScope unit="page" from="700" to="710" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Different activation signals induce distinct mast cell degranulation strategies</title>
		<author>
			<persName><forename type="first">N</forename><surname>Gaudenzio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sibilano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Marichal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Starkl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Reber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Cenac</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Mcneil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Dong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Hernandez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sagi-Eisenberg</surname></persName>
		</author>
		<idno type="DOI">10.1172/JCI85538</idno>
	</analytic>
	<monogr>
		<title level="j">J. Clin. Investig</title>
		<imprint>
			<biblScope unit="volume">126</biblScope>
			<biblScope unit="page" from="3981" to="3998" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Regulation of FoxP3 regulatory T cells and Th17 cells by retinoids</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
		<idno type="DOI">10.1155/2008/416910</idno>
	</analytic>
	<monogr>
		<title level="j">Clin. Dev. Immunol</title>
		<imprint>
			<biblScope unit="page">416910</biblScope>
			<date type="published" when="2008">2008. 2008</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Regulation of B cell proliferation and differentiation by retinoic acid</title>
		<author>
			<persName><forename type="first">A</forename><surname>Ertesvåg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Naderi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">K</forename><surname>Blomhoff</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.smim.2008.06.005</idno>
	</analytic>
	<monogr>
		<title level="j">Semin. Immunol</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="36" to="41" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">A long-term coculture model for the study of mast cell-keratinocyte interactions</title>
		<author>
			<persName><forename type="first">M</forename><surname>Artuc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">M</forename><surname>Steckelings</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Grutzkau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Smorodchenko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Henz</surname></persName>
		</author>
		<idno type="DOI">10.1046/j.1523-1747.2002.01838.x</idno>
	</analytic>
	<monogr>
		<title level="j">J. Investig. Dermatol</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="page" from="411" to="415" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Integration of the human dermal mast cell into the organotypic co-culture skin model</title>
		<author>
			<persName><forename type="first">J</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Guhl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Babina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Zuberbier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Artuc</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Methods Mol. Biol</title>
		<imprint>
			<biblScope unit="volume">1192</biblScope>
			<biblScope unit="page" from="69" to="85" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Skin mast cell phenotypes between two highly divergent cohorts-More pronounced variability within than between groups</title>
		<author>
			<persName><forename type="first">M</forename><surname>Babina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Guhl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Artuc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Zuberbier</surname></persName>
		</author>
		<idno type="DOI">10.1111/exd.13227</idno>
	</analytic>
	<monogr>
		<title level="j">Exp. Dermatol</title>
		<imprint>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">The transcription factor profile of human mast cells in comparison with monocytes and granulocytes</title>
		<author>
			<persName><forename type="first">M</forename><surname>Babina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Schulke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Kirchhof</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Guhl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Franke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bohm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Zuberbier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Henz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Gombart</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00018-004-4480-6</idno>
	</analytic>
	<monogr>
		<title level="j">Cell. Mol. Life Sci</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="214" to="226" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Biochemical and histochemical evaluation of tryptase in various human tissues</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">T</forename><surname>Harvima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Karkola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Harvima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Naukkarinen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Neittaanmaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Horsmanheimo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Fraki</surname></persName>
		</author>
		<idno type="DOI">10.1007/BF00431056</idno>
	</analytic>
	<monogr>
		<title level="j">Arch. Dermatol. Res</title>
		<imprint>
			<biblScope unit="volume">281</biblScope>
			<biblScope unit="page" from="231" to="237" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
